... , with M. D. Anderson enrolling 20 patients. All of the women were newly diagnosed with metastatic breast cancer and were hormone receptor positive and estrogen receptor HER-2 negative. Patients were ...
Lapatinib reduces the number of large brain metastases in a mouse model of metastatic breast cancer, relative to untreated mice, researchers report.
... offers an appealing alternative to chemotherapy for metastatic breast cancer that has become resistant to estrogen-lowering ... 40,000 women die of metastatic breast cancer each year, and estrogen therapy ...
Estrogen-receptor positive metastatic breast cancer often develops resistance to conventional therapies that severely lower a woman's estrogen level. A group of researchers headed by a breast cancer ...
... of Clinical Oncology.
Trastuzumab is standard therapy for women with HER2-positive metastatic breast cancer and the majority of women respond to the treatment. However, over time some women will ...
... cancer bone metastasis genes. Dr. Kang and colleagues now show how alterations in MMP1 ... activity may represent a viable method of mitigating bone complications in advanced metastatic breast cancers.
Both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and disease- ...
... 30 percent of women whose metastatic breast cancer no longer responded to standard ... treatment, which severely lowers estrogen levels, but their metastatic tumors had later reappeared or resumed growing ...
... measured the number of circulating tumor cells (CTC) in blood collected from women with metastatic breast cancer. About one tablespoon of blood was collected every three to four weeks. The number of ...
... blood test can help doctors more reliably assess treatment efficacy for patients with metastatic breast cancer. Circulating tumor cells are a reliable predictor of treatment response in metastatic ...
... also plans to open a clinical trial with metformin in combination with hormonal therapy for metastatic breast cancer patients who are obese. The study will be led by Francisco Esteva, M.D., Ph.D., ...
... IL-8 are associated with aggressive metastatic breast cancer in women. Our laboratory has found that IL-8 ... role for IL-8 in blocking the progression of cancer and metastasis," says Dr. Wu. "Because IL ...
... and abnormal cortisol (a steroid hormone that regulates blood pressure), rhythms in metastatic breast cancer, thus concluding that a disrupted cortisol rhythm may have serious medical implications in ...
... Lipper Biophotonics Center, provides detail on how cancer cells invade surrounding tissue and reach ... Society reported that a woman with metastatic breast cancer had an average survival rate of two years ...
... investigating how best to tether other molecules to the antibody in order to target metastatic breast cancer and related diseases."
According to Robinson, ALM might also provide a platform for ...
